According to a recent LinkedIn post from ABM Respiratory Care, the company is participating as a sponsor of NYU Langone’s “Ambulatory Critical Care: Advancing the Field of Home Mechanical Ventilation” program in New York City on March 13–14. The educational event focuses on care for patients transitioning from hospital to home, with 9.75 continuing education credits offered to attendees.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights that participants attending in person may engage in hands-on simulation sessions featuring ABM’s BiWaze Cough and BiWaze Clear systems. For investors, this sponsorship and product exposure at a specialized clinical education forum may support brand awareness, clinician adoption, and longer-term demand for the company’s home ventilation and airway clearance technologies.
The post suggests that ABM Respiratory Care is positioning its BiWaze platform within the growing market for home-based respiratory care and non-invasive ventilation. Increased visibility among respiratory specialists and care teams at NYU Langone and beyond could translate into broader clinical validation and potential expansion of the company’s customer base over time.
By aligning with a continuing medical education program, ABM Respiratory Care appears to be targeting influential decision-makers in hospital-to-home care pathways. While immediate revenue impact is unclear, this type of engagement can strengthen the company’s industry presence and support future commercialization efforts in the home mechanical ventilation segment.